We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > neck

News List

ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients drugs
September 24, 2019
Nonsteroidal anti-inflammatory drugs (NSAIDs) are correlated with better overall survival in patients with head and neck squamous cell carcinoma (HNSCC) ...
Delaying Treatment Worsens Head, Neck Cancer Outcomes drugs
September 17, 2019
Delaying time to treatment initiation (TTI) beyond 60 days is associated with decreased overall survival and increased head and neck cancer recurrence
FDA Approves Keytruda (pembrolizumab) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma drugs
June 12, 2019
FDA Approves Keytruda (pembrolizumab) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma.
Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer drugs
June 11, 2019
Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer.
NICE turns down BMS' Opdivo for head and neck cancer pharmafile
April 11, 2017
Bad news for Bristol-Myers Squibb as NICE chooses not to recommend its immunotherapy drug Opdivo (nivolumab) for use in head and neck cancer treatment.